GH-IGF-1 Axis in Children with Cystic Fibrosis
Sara Pagani1, Elena Bozzola2, Gloria Acquafredda3
1Unit of Pediatrics and Adolescentology, Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Insights
Children with cystic fibrosis (CF) show improved growth hormone receptor (GHR) gene expression and insulin-like growth factor-I (IGF-I) levels with early diagnosis. Newborn screening for CF may prevent growth retardation by reducing symptom duration.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Pulmonology
Background:
- Cystic Fibrosis (CF) is a genetic disorder associated with chronic inflammation and malnutrition, potentially impacting growth.
- The growth hormone receptor (GHR) and insulin-like growth factor-I (IGF-I) axis are crucial for childhood growth.
- Understanding GHR gene expression in CF patients is important for assessing growth disturbances.
Purpose of the Study:
- To investigate the role of growth hormone receptor (GHR) gene expression in the growth of children with cystic fibrosis (CF).
- To compare growth parameters and GHR gene expression between CF patients diagnosed via newborn screening (NBS) versus late diagnosis (LD) and healthy controls.
Main Methods:
- A cohort of 49 prepubertal children with CF and 52 healthy controls were studied.
- Blood samples were collected to measure insulin-like growth factor-I (IGF-I), growth hormone-binding protein (GHBP), and GHR gene expression.
- Body mass index (BMI), height, and weight were compared between groups using ELISA and real-time PCR.
Main Results:
- CF patients showed significant BMI increase from diagnosis to follow-up, with lower initial median BMI compared to controls.
- Significantly higher IGF-I and GHBP levels were observed in CF patients (both NBS and LD groups) compared to controls at follow-up.
- GHR mRNA expression was significantly increased in LD patients and higher in both CF groups compared to controls.
Conclusions:
- Children with late-diagnosed CF exhibit normal growth hormone/IGF-I axis function and good auxological values.
- Early diagnosis of CF through newborn screening may further prevent growth retardation by minimizing symptom duration.
- GHR gene expression appears to play a role in the growth of children with CF, particularly in those with late diagnosis.
Objective:
To verify whether growth hormone receptor (GHR) gene expression plays a role in growth of children with cystic fibrosis (CF), as a consequence of the chronic inflammatory condition and malnutrition.
Design:
We enrolled 49 prepubertal patients (24 males and 25 females) affected by CF in a stable clinical condition, 19 of whom had been diagnosed through newborn screening and 30 following presentation of symptoms. Patients had no significant comorbidity affecting growth or cystic fibrosis transmembrane conductance regulator (CFTR)-related diabetes requiring insulin therapy. Blood was collected during two follow-up visits to measure insulin-like growth factor (IGF-I), growth hormone-binding protein (GHBP), and GHR gene expression. Recruited as a control group were 52 healthy children, sex- and age-matched, were recruited as a control group.
Methods:
We compared body mass index (BMI), height, weight, IGF-I, GHBP, and GHR gene expression values (evaluated by Chemiluminescent Immunometric assay; ELISA and real-time PCR, respectively) in CF patients diagnosed through newborn screening (NBS) or by symptoms (late diagnosis [LD]) and in healthy controls.
Results:
BMI increased significantly in patients between the time of diagnosis and check-up (P<0.001), particularly in the LD group; median value was lower at diagnosis and significantly higher (P<0.001) at follow-up visits compared to controls. At initial evaluation, higher levels of IGF-I (not statistically significant) were found in both the NBS group and the LD group compared to the control group. At the second evaluation, significantly higher levels of IGF-I (P=0.003) were found in both the NBS and LD groups compared to controls; GHR mRNA expression had significantly increased (P=0.013) in LD patients compared with the first evaluation and was significantly higher in the NBS and LD groups than in controls. GHBP values had significantly increased (P=0.047) in the NBS group after one year of therapy compared to first visit levels and were significantly higher (P<0,0001) in the NBS and LD groups compared to controls.
Conclusion:
In our LD patients during childhood, we observed good auxological values and a GH/IGF-I axis function within normal range for the factor evaluated. However, earlier diagnosis through NBS might further minimize and prevent growth retardation, by reducing the duration of symptoms before treatment.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Cystic Fibrosis: Management
Sinus disease and chronic...
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
07:56Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis
07:25Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients


